Molecular and cellular biomarkers for angiogenesis in clinical oncology

被引：67

作者：

Bertolini, Francesco ^{[1
]}

Mancuso, Patrizia

Shaked, Yuval

Kerbel, Robert S.

机构：

[1] European Inst Oncol, Dept Med, Div Hematol Oncol, I-20141 Milan, Italy

[2] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med Biophys, Toronto, ON M4N 3M5, Canada

来源：

DRUG DISCOVERY TODAY | 2007年 / 12卷 / 19-20期

关键词：

D O I：

10.1016/j.drudis.2007.08.011

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Medical oncologists are increasingly using anti-angiogenic drugs, but identifying the best-suited drug and the optimal dosage and schedule for treatment of patients remain challenging issues. Circulating endothelial cells (CECs) and circulating endothelial progenitors (CEPs) are modulated in a variety of diseases including cancer, and are promising surrogate biomarkers in oncology. Molecular surrogate markers, on the other hand, are more scanty at the present time, because the identification of truly endothelial cell-restricted genes and/or antigens is complex. Here, we discuss the biological and technical facets of the search and validation of new biomarkers for angiogenesis.

引用

收藏

页码：806 / 812

页数：7

相关论文

共 78 条

[71] Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature [J].

van Beijnum, Judy R. ;

Dings, Ruud P. ;

van der Linden, Edith ;

Zwaans, Bernadette M. M. ;

Ramaekers, Frans C. S. ;

Mayo, Kevin H. ;

Griffioen, Arjan W. .

BLOOD, 2006, 108 (07) :2339-2348

[72] Promise of new vascular-disrupting agents balanced with cardiac toxicity: Is it time for oncologists to get to know their cardiologists? [J].

van Heeckeren, WJ ;

Bhakta, S ;

Ortiz, J ;

Duerk, J ;

Cooney, MM ;

Dowlati, A ;

McCrae, K ;

Remick, SC .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (10) :1485-1488

[73] Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal of a definition and a consensus protocol [J].

Woywodt, A ;

Blann, AD ;

Kirsch, T ;

Erdbruegger, U ;

Banzet, N ;

Haubitz, M ;

Dignat-George, F .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (03) :671-677

[74] Functional neoangiogenesis imaging of genetically engineered mouse prostate cancer using three-dimensional power Doppler ultrasound [J].

Xuan, Jim W. ;

Bygrave, Michael ;

Jiang, Hongyi ;

Valiyeva, Fatma ;

Dunmore-Buyze, Joy ;

Holdsworth, David W. ;

Izawa, Jonathan I. ;

Bauman, Glenn ;

Moussa, Madeleine ;

Winter, Scott F. ;

Greenberg, Norman M. ;

Chin, Joseph L. ;

Drangova, Maria ;

Fenster, Aaron ;

Lacefield, James C. .

CANCER RESEARCH, 2007, 67 (06) :2830-2839

[75] Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals [J].

Yoder, Mervin C. ;

Mead, Laura E. ;

Prater, Daniel ;

Krier, Theresa R. ;

Mroueh, Karim N. ;

Li, Fang ;

Krasich, Rachel ;

Temm, Constance J. ;

Prchal, Josef T. ;

Ingram, David A. .

BLOOD, 2007, 109 (05) :1801-1809

[76] Identification and clinical significance of mobilized endothelial progenitor cells in tumor vasculogenesis of hepatocellular carcinoma [J].

Yu, Decai ;

Sun, Xitai ;

Qiu, Yudong ;

Zhou, Jianxing ;

Wu, Yafu ;

Zhuang, Lingyuan ;

Chen, Jun ;

Ding, Yitao .

CLINICAL CANCER RESEARCH, 2007, 13 (13) :3814-3824

[77] Circulating endothelial progenitor cells in multiple myeloma:: implications and significance [J].

Zhang, H ;

Vakil, V ;

Braunstein, M ;

Smith, ELP ;

Maroney, J ;

Chen, L ;

Dai, KZ ;

Berenson, JR ;

Hussain, MM ;

Klueppelberg, U ;

Norin, AJ ;

Akman, HO ;

Özçelik, T ;

Batuman, OA .

BLOOD, 2005, 105 (08) :3286-3294

[78]

2000, J CLIN INVEST, V105, P71

← 1 2 3 4 5 6 7 8 →